Endothelial Nitric Oxide Synthase-Dependent Mechanism of Hydroxyurea-Induced S-Phase Arrest in Erythroid Cells

Hydroxyurea (HU) is a ribonucleotide reductase inhibitor widely used for the treatment of sickle cell disease and myeloproliferative disorders, yet a precise nitric oxide (NO) synthase (NOS)-dependent mechanism remains incompletely defined. The role of NOS3 in HU-mediated proliferation, cell cycle,...

Полное описание

Библиографические подробности

Главные авторы:	Teodora Dragojević, Dragoslava Đikić, Slavko Mojsilović, Miloš Lazarević, Dejan Milenković, Olivera Mitrović Ajtić, Emilija Živković, Miloš Diklić, Tijana Subotički, Juan F. Santibanez, Vladan P. Čokić, Milica Vukotić
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2026-03-01
Серии:	Antioxidants
Предметы:	hydroxyurea nitric oxide synthase replicative stress proliferation apoptosis
Online-ссылка:	https://www.mdpi.com/2076-3921/15/4/435
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!